[Treatment of resistance to subcutaneous insulin with implanted insulin infusion pumps]. 1988

S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
Krankenhaus Wien-Lainz, Osterreich.

Four female patients, resistant to insulin administered subcutaneously, were treated with an implanted insulin infusion pump (Infusaid; constant rate infusion). They had all experienced as many as four episodes of ketoacidosis per month despite extremely high doses of insulin injected subcutaneously or intramuscularly, and none of the treatment approaches attempted--insulin delivery via subclavian catheter, Schade-port, insulin infusion with an external portable pump or various insulin additives--had been successful. After implantation of the pump the daily insulin dose, which had been between 300 and 3000 units during subcutaneous therapy, was reduced to 30 to 70 units per day. The patients' condition improved, no further episodes of ketoacidosis occurred and hospital stays were reduced significantly. In the further course of treatment pump and catheter-related complications had to be overcome.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007332 Insulin Infusion Systems Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor. Pancreas, Artificial Endocrine,Programmable Implantable Insulin Pump,beta Cell, Artificial,Implantable Programmable Insulin Pump,Insulin Pump, Programmable Implantable,Pump, Programmable Implantable Insulin,Artificial Endocrine Pancreas,Artificial beta Cell,Artificial beta Cells,Cell, Artificial beta,Cells, Artificial beta,Endocrine Pancreas, Artificial,Infusion System, Insulin,Infusion Systems, Insulin,Insulin Infusion System,System, Insulin Infusion,Systems, Insulin Infusion,beta Cells, Artificial
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016883 Diabetic Ketoacidosis A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by KETOSIS; DEHYDRATION; and depressed consciousness leading to COMA. Acidosis, Diabetic,DKA Diabetic Ketoacidosis,Diabetic Acidosis,Diabetic Ketosis,Ketoacidosis, Diabetic,Ketosis, Diabetic,Acidoses, Diabetic,DKA Diabetic Ketoacidoses,Diabetic Acidoses,Diabetic Ketoacidoses,Diabetic Ketoacidosis, DKA,Diabetic Ketoses,Ketoacidoses, Diabetic,Ketoacidosis, DKA Diabetic,Ketoses, Diabetic

Related Publications

S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
October 1984, The New England journal of medicine,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
January 2005, Revue medicale de Liege,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
January 2012, Advances in experimental medicine and biology,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
December 1989, Irish medical journal,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
December 1990, Diabetic medicine : a journal of the British Diabetic Association,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
January 2009, Journal of the American Pharmacists Association : JAPhA,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
April 1988, Scottish medical journal,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
January 2010, Cancer journal (Sudbury, Mass.),
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
May 1991, Soins; la revue de reference infirmiere,
S Löchli, and I Campbell, and H Dorenboos, and K R Paterson, and J G Devlin, and G Hagmüller, and K Irsigler
June 1982, The Journal of the Medical Society of New Jersey,
Copied contents to your clipboard!